FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/25/2026
Back to search
Official data from USPTO
SYNI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/25/2026
Trademark type
Word
Nice classes
5
Filing date
11/29/2024
Registration date
10/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/14/2025
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
GARCIA, CLAUDIA
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BIOGENCY PTY LTD
Representatives
Stephen Drysdale
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Food supplementsanti-oxidants; capsules sold empty for pharmaceutical purposes; capsules sold empty for veterinary pharmaceutical preparations; chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; collagen based medicated supplements for use as nutritional supplements; decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; antioxidants in the nature of dietary supplements; dietary protein supplements; dietary supplements; dietary supplements for animals; dietary supplements with a cosmetic effect; effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; food supplements for medical purposes to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; herbal dietary supplements; dietary nutritional supplements; nutritional supplements; plant extractsother than essential oilsbeing dietary supplements; medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; pharmaceutical preparations to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical preparations for skin care; pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; chemical products in the nature of chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; natural pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; pharmaceutical products to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; tablets being pharmaceuticals to support nicotinamide adenine dinucleotide productioncell metabolism and energy productionmaintain cardiovascular healthsupport blood capillary healthrelieve inflammation of joints; food supplements for animals in the nature of vitamins; vitamin supplements; dietary food supplements; nutritional drinks being dietary food supplements; food supplements in the nature of dietary supplements.
Publications
History of USPTO decisions and trademark events.
27 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/18/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/31/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/24/2026
FIMP
FINAL DISPOSITION PROCESSED
04/24/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/14/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/26/2025
PUBO
PUBLISHED FOR OPPOSITION
08/26/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/20/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2025
RFNT
REFUSAL PROCESSED BY IB
07/05/2025
ALIE
ASSIGNED TO LIE
06/24/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/14/2025
RFRR
REFUSAL PROCESSED BY MPU
06/14/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/11/2025
CNRT
NON-FINAL ACTION WRITTEN
04/10/2025
DOCK
ASSIGNED TO EXAMINER
04/09/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/14/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/14/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
01/14/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/02/2025
Continuous trademark protection
Get notified about every new filing that threatens SYNI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.